Its new five-year, $9.7 billion contract with Microsoft is a game changer. Iren plans to expand its hardware backbone to ...

Discover why Tomra (TMRAY) is rated 'Buy' with strong fundamentals, growth potential, and EU regulatory support.

Two under‑the‑radar Canadian plays pair mission‑critical growth with paycheque‑like income you can hold for decades.

This Canadian growth stock has consistently outperformed the broader market and is set to deliver above-average returns in ...

Creative software giant Adobe (NASDAQ:ADBE) reported Q4 CY2025 results , with sales up 10.5% year on year to $6.19 billion.

Worried about high valuations? KBE, XRT, and XPH with low P/Es and fresh momentum are three undervalued ETFs to consider as ...

The U.S. stock market is flirting with its all-time high after the Federal Reserve cut its main interest rate to bolster the ...

Recent commentary about softer U.S. travel demand has spooked Marriott's near-term outlook but not its long-term story.

These five top blue chip dividend stocks offer growth and income investors a solid opportunity to generate passive income and total return.

Elon Musk's SpaceX, which has prominent operations in Florida, could be moving toward a public listing in 2026, according to ...

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

Concentra Group Holdings Parent, Inc. (NYSE:CON) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, Concentra Group Holdings Parent, Inc.